Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 4 of 4
Full-Text Articles in Medicine and Health Sciences
Inhibition Of Hmgb1/Rage-Mediated Endocytosis By Hmgb1 Antagonist Box A, Anti-Hmgb1 Antibodies, And Cholinergic Agonists Suppresses Inflammation, H. Yang, H. Liu, Q. Zeng, G. H. Imperato, M. E. Addorisio, M. He, K. F. Cheng, Y. Al-Abed, S. S. Chavan, K. J. Tracey, +3 Additional Authors
Inhibition Of Hmgb1/Rage-Mediated Endocytosis By Hmgb1 Antagonist Box A, Anti-Hmgb1 Antibodies, And Cholinergic Agonists Suppresses Inflammation, H. Yang, H. Liu, Q. Zeng, G. H. Imperato, M. E. Addorisio, M. He, K. F. Cheng, Y. Al-Abed, S. S. Chavan, K. J. Tracey, +3 Additional Authors
Journal Articles
No abstract provided.
Targeting Dec-205(-)Dcir2(+) Dendritic Cells Promotes Immunological Tolerance In Proteolipid Protein-Induced Experimental Autoimmune Encephalomyelitis, I. Tabansky, D. B. Keskin, D. Watts, C. Petzold, M. Funaro, W. Sands, P. Wright, S. Najjar, B. Diamond, J. N. H. Stern, +4 Additional Authors
Targeting Dec-205(-)Dcir2(+) Dendritic Cells Promotes Immunological Tolerance In Proteolipid Protein-Induced Experimental Autoimmune Encephalomyelitis, I. Tabansky, D. B. Keskin, D. Watts, C. Petzold, M. Funaro, W. Sands, P. Wright, S. Najjar, B. Diamond, J. N. H. Stern, +4 Additional Authors
Journal Articles
No abstract provided.
Identification Of Ethyl Pyruvate As A Nlrp3 Inflammasome Inhibitor That Preserves Mitochondrial Integrity, S. Li, F. Liang, K. Kwan, Y. Tang, X. Wang, H. Yang, S. S. Chavan, H. Wang, K. J. Tracey, +3 Additional Authors
Identification Of Ethyl Pyruvate As A Nlrp3 Inflammasome Inhibitor That Preserves Mitochondrial Integrity, S. Li, F. Liang, K. Kwan, Y. Tang, X. Wang, H. Yang, S. S. Chavan, H. Wang, K. J. Tracey, +3 Additional Authors
Journal Articles
No abstract provided.
Network Modulation Following Sham Surgery In Parkinson's Disease, J. H. Ko, A. Feigin, P. Mattis, C. C. Tang, Y. L. Ma, V. Dhawan, M. J. During, M. G. Kaplitt, D. Eidelberg
Network Modulation Following Sham Surgery In Parkinson's Disease, J. H. Ko, A. Feigin, P. Mattis, C. C. Tang, Y. L. Ma, V. Dhawan, M. J. During, M. G. Kaplitt, D. Eidelberg
Journal Articles
Patient responses to placebo and sham effects are a major obstacle to the development of therapies for brain disorders, including Parkinson's disease (PD). Here, we used functional brain imaging and network analysis to study the circuitry underlying placebo effects in PD subjects randomized to sham surgery as part of a double-blind gene therapy trial. Metabolic imaging was performed prior to randomization, then again at 6 and 12 months after sham surgery. In this cohort, the sham response was associated with the expression of a distinct cerebello-limbic circuit. The expression of this network increased consistently in patients blinded to treatment and …